The Director of Oncology US Market Access Marketing will lead market access marketing strategy for VENCLEXTA (venetoclax), an oral oncolytic jointly commercialized by AbbVie and Genentech. VENCLEXTA is approved for Chronic Lymphocytic Leukemia (CLL) and Acute Myeloid Leukemia (AML). The Director will lead market access strategy and manage two direct reports, with accountability for contracting and customer engagement across payer channels—including Commercial, Medicare, Medicaid, and VA—as well as GPO and Community Oncology. The role leads strategic alignment with the Market Access field and coordinates strategy, communication, and alignment across US Market Access Channel and Policy teams. As the Market Access Marketing subject matter expert for the VENCLEXTA Integrated Brand Teams, the Director develops market access strategies with stakeholders in the Oncology commercial organization and US Medical Affairs. The Director also manages market access interactions and collaborative relationships with Genentech staff, including Joint Commercialization Council decision-making with senior leaders from both companies. The Director leads market access components of key account strategy across AbbVie and Genentech functions, translating VENCLEXTA’s clinical and economic profile into value propositions and resources for payer, provider institution, government, and community audiences. The role applies data, analytics, and strategic thinking to the marketing business, provides positive leadership, and supports cultural alignment with US Market Access’s Ambitious Cultural Vision.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director